A recent in vitro study showed that interleukin-38 (IL-38) has an increased level of peri-myocardial infarction and that the phenomenon of myocardial remodeling has been markedly improved after the administration of recombinant IL-38. Here, IL1F10 is linked to myocardial infarction.